Caring Brands completed an initial private Placement closing that produced $4,600,000, issuing 4,600 Series B Preferred Shares plus warrants for 4,600,000 common shares in each of two series. The structure may dilute existing holders through conversion and Warrant exercise, while proceeds are intended for Working Capital and general corporate purposes.
Key Highlights
- The 4,600 Series B preferred shares are initially convertible into 6,571,428 common shares at $0.70 per share.
- Subscription documents for an additional $4,400,000 have been executed, with a closing expected by September 4 if conditions are met.
- Caring Brands completed an initial private placement closing generating $4,600,000 in gross proceeds before offering expenses.
- The transaction issued 4,600 Series B Convertible Preferred Stock shares and warrants covering up to 4,600,000 common shares in each of two series.
Caring Brands, Inc. (NASDAQ: CABR) completed an initial private placement closing that generated $4,600,000 in gross proceeds before offering expenses. The transaction issued 4,600 Series B Convertible Preferred Stock shares, along with warrants covering up to 4,600,000 common shares in each of two series.
Preferred Stock and Warrants Set Initial Terms
The Securities Purchase Agreement, entered into with accredited investors on August 21, allows Caring Brands to sell up to 11,000 Series B preferred shares at $1,000 per share. The Series A Warrants carry an exercise price of $0.825 per common share, while the Series B Warrants have an exercise price of $0.95 per common share. An additional $4,400,000 in subscription documents has been executed. After those funds clear, Caring Brands expects to issue 4,400 more preferred shares and warrants covering up to 4,400,000 common shares for each series, on or before September 4, subject to closing conditions. The securities were sold only to investors who were parties to the agreement and were not registered under the Securities Act. The Equity figure is preliminary and unaudited.
FAQs
Q: What did Caring Brands raise in the initial closing?
A: Caring Brands received $4,600,000 in gross proceeds from issuing 4,600 Series B preferred shares. The closing also included Series A and Series B warrants tied to common stock purchases.
Q: How could the CABR financing affect shareholders?
A: The preferred stock is initially convertible into 6,571,428 common shares, while both warrant series cover additional common stock purchases. Caring Brands identifies dilution as a risk.
Q: Will Caring Brands complete another closing?
A: Caring Brands expects an additional closing on or before September 4, subject to closing conditions and the release of subscription funds. Completion, timing and amount remain uncertain.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.